2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm: The Relationship of Neuropsychiatric Symptoms and Cognitive Impairment in Parkinson’s Disease

B. Bernard, G. Stebbins, A. Negron, D. Merkitch, J. Goldman (Chicago, IL, USA)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: The relationship of non-motor symptoms with the dominant symptom and the stage of patients with Parkinson’s disease

E. Tur, M. Demir, G. Kenangil (Istanbul, Turkey)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: The right hemisphere inhibitory network in patients with asymmetrical Parkinson’s disease: An fMRI study

F. Lazoya, I. Obeso, R. Gonzales Redondo, F. Villagra, E. Luis, J. Obeso, M. Jahanshahi, M. Pastor (Pamplona, Spain)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: The role of lipid metabolism in mouse models of Parkinson’s disease

M. Trabjerg, D. Andersen, P. Huntjens, K. Mørk, M. Skjønnemand, M. Oklinski, A. Mørkholt, I. Huijbers, C. Pritchard, L. Kroese, J. Nieland (Aalborg, Denmark)

Physiology and Pathophysiology · Les Muses, Level 3

1:15pm-2:45pm: The role of Synaptic vesicle protein 2A (SV2A) in patients with Parkinson’s disease dementia and Dementia with Lewy bodies: An in vivo [11C]UCB-J PET study

H. Wilson, G. Dervenoulas, G. Pagano, A. Chandra, F. Niccolini, M. Esposito, R. Gunn, L. Ricciardi, E. Rabiner, D. Aarsland, M. Politis (London, United Kingdom)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: The social interaction in patients with Parkinson’s disease from the points of activities of daily living and motor function

A. Kumon, M. Sagawa, M. Saruwatari, N. Kawashima, K. Hasegawa (Fujisawa, Japan)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: The spectrum of involuntary vocalizations in humans

T. Mainka, B. Balint, F. Gövert, L. Kurvits, C. van Riesen, A. Kühn, M. Tijssen, A. Lees, K. Müller-Vahl, K. Bhatia, C. Ganos (London, United Kingdom)

Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3

1:15pm-2:45pm: The Urge to Move in Restless Legs Syndrome Associated with Parkinson’s Disease: A Motor Impulse Control Disorder?

A. Marques, C. Lambert, T. Vidal, F. Durif, M. Fantini (Clermont-Ferrand, France)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: The Use of Diffusion Weighted Imaging to Detect Structural Biomarkers in Recently-Diagnosed Parkinson’s Disease Patients

P. Macdonald, N. Handfield-Jones, E. Alushaj, N. Hiebert, A. Owen, A. Khan (London, ON, Canada)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: The utility of DCTclock™ (the digital clock drawing test) for unmasking early cognitive decline in Parkinson’s disease

T. Schejter Margalit, R. Kizony, B. Cohen, A. Thaler, W. Souillard-Mandar, A. Holway, V. Irzhevsky, A. Orr-Urtreger, J. Cederbaum, N. Giladi, A. Mirelman (Tel Aviv, Israel)

Cognition and Cognitive Disorders · Agora 3 East, Level 3